Passage BIO PASG
NASDAQ PASG
$4.44 -0.04 (-0.89%)
At close: Aug 21, 2026 · 4:00 PM EDT

Passage BIO (PASG) Property, Plant & Equipment (Net) (2019 - 2026)

Passage BIO (PASG) Property, Plant & Equipment (Net) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Passage BIO 13.99 Mn 13.99 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 826,000.00
Mar 31, 2026 826,000.00
Dec 31, 2025 4.11 Mn
Dec 31, 2025 4.11 Mn
Sep 30, 2025 5.16 Mn
Sep 30, 2025 5.16 Mn
Jun 30, 2025 5.34 Mn
Jun 30, 2025 5.34 Mn
Mar 31, 2025 5.52 Mn
Mar 31, 2025 5.52 Mn
Dec 31, 2024 9.33 Mn
Dec 31, 2024 9.33 Mn
Sep 30, 2024 10.04 Mn
Sep 30, 2024 10.04 Mn
Jun 30, 2024 13.05 Mn
Jun 30, 2024 13.05 Mn
Mar 31, 2024 14.49 Mn
Mar 31, 2024 14.49 Mn
Dec 31, 2023 15.30 Mn
Dec 31, 2023 15.30 Mn